Given that CA-125 is commonly measured in the clinical setting for cancer monitoring, we repeated the CA-125 measurements using Cobas (Elecsys CA 125 II, Roche diagnostics) –the method used by LSH. The gene discussed is MUC16; the disease is cancer.